Kirsten Flowers News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Kirsten flowers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Kirsten Flowers Today - Breaking & Trending Today

Kura Oncology, Inc. (NASDAQ:KURA) Expected to Earn FY2025 Earnings of ($2.04) Per Share

Kura Oncology, Inc. (NASDAQ:KURA – Get Rating) – Research analysts at HC Wainwright lifted their FY2025 earnings estimates for Kura Oncology in a research report issued on Monday, April 17th. HC Wainwright analyst J. Pantginis now forecasts that the company will post earnings of ($2.04) per share for the year, up from their prior forecast […] ....

Kathleen Ford , Stifel Nicolaus , Artal Group , Victory Capital Management Inc , Kura Oncology Inc , Armistice Capital , Verition Fund Management , Kura Oncology , Get Rating , Kirsten Flowers , Street Corp , Capital Management , Solid Tumors , Chronic Myelomonocytic Leukemia , Kura Oncology Daily , Nasdaq Kura , Earnings Estimates , Hc Wainwright ,

Kura Oncology (NASDAQ:KURA) Shares Down 5.3%

Kura Oncology, Inc. (NASDAQ:KURA – Get Rating)’s share price was down 5.3% during mid-day trading on Tuesday . The company traded as low as $10.88 and last traded at $10.90. Approximately 135,098 shares traded hands during trading, a decline of 79% from the average daily volume of 632,237 shares. The stock had previously closed at […] ....

Kathleen Ford , Stifel Nicolaus , Kura Oncology Inc , Victory Capital Management Inc , Allspring Global Investments Holdings , Raymond James Associates , Metlife Investment Management , Kura Oncology , Get Rating , Oncology Stock Down , Kirsten Flowers , Global Investments Holdings , Life Investment Management , Capital Management , Solid Tumors , Chronic Myelomonocytic Leukemia , Kura Oncology Daily , Nasdaq Kura ,

Kura Oncology, Inc. (NASDAQ:KURA) Receives $31.50 Consensus PT from Brokerages

Shares of Kura Oncology, Inc. (NASDAQ:KURA – Get Rating) have earned an average recommendation of “Moderate Buy” from the six brokerages that are presently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation and five have given a buy recommendation to the company. The average 12 […] ....

Zurcher Kantonalbank Zurich Cantonalbank , Stifel Nicolaus , Kathleen Ford , Great West Life Assurance Co , Kura Oncology Inc , Annandale Capital , Kura Oncology Company Profile , Kura Oncology , Get Rating , Marketbeat Ratings , Kirsten Flowers , West Life Assurance , Kantonalbank Zurich Cantonalbank , Technologies Capital Management , Solid Tumors , Chronic Myelomonocytic Leukemia , Kura Oncology Daily , Nasdaq Kura ,